Vascular proteomics in metabolic and cardiovascular diseases. (4th March 2016)

• Record Type: Journal Article
• Authors: Lynch, M.; Barallobre‐Barreiro, J.; Jahangiri, M.; Mayr, M.
• Is Part Of: Journal of internal medicine. Volume 280:Number 4(2016:Oct.)
• Page Start: 325
• Page End: 338
• Publication Date: 2016-03-04
• Subjects: apolipoproteins -- atherosclerosis -- diabetes -- proteomics -- restenosis -- vascular biology; Internal medicine -- Periodicals; Medicine -- Periodicals; 616
• DOI: 10.1111/joim.12486
• Languages: English
• ISSNs: 0954-6820

Abstract

Abstract: The vasculature is essential for proper organ function. Many pathologies are directly and indirectly related to vascular dysfunction, which causes significant morbidity and mortality. A common pathophysiological feature of diseased vessels is extracellular matrix (ECM) remodelling. Analysing the protein composition of the ECM by conventional antibody‐based techniques is challenging; alternative splicing or post‐translational modifications, such as glycosylation, can mask epitopes required for antibody recognition. By contrast, proteomic analysis by mass spectrometry enables the study of proteins without the constraints of antibodies. Recent advances in proteomic techniques make it feasible to characterize the composition of the vascular ECM and its remodelling in disease. These developments may lead to the discovery of novel prognostic and diagnostic markers. Thus, proteomics holds potential for identifying ECM signatures to monitor vascular disease processes. Furthermore, a better understanding of the ECM remodelling processes in the vasculature might make ECM‐associated proteins more attractive targets for drug discovery efforts. In this review, we will summarize the role of the ECM in the vasculature. Then, we will describe the challenges associated with studying the intricate network of ECM proteins and the current proteomic strategies to analyse the vascular ECM in metabolic and cardiovascular diseases.